Eurobank Cyprus has made significant investments in research and innovation, and the fruitful outcomes are now evident. In a recent announcement, Eurobank Cyprus highlighted the success of two research teams from Cypriot academic institutions, which received support from the esteemed Cyprus Seeds program. These teams have already established their own thriving startups, demonstrating great potential for the future and offering manifold benefits to the entrepreneurial, research, and innovation landscape in Cyprus.

One notable success story is GYNETRONICS LTD, a pioneering startup born out of a scientific collaboration between Professor Vasilis Tanos from Womana LTD and Professor Ioulios Georgiou from the University of Cyprus. GYNETRONICS LTD has developed an innovative medical device capable of conducting non-invasive electromyography of the uterus in non-pregnant women, analogous to electrocardiography for the heart. This breakthrough technology holds immense promise for enhancing the diagnosis and treatment of uterine conditions, as well as assisting couples struggling with fertility difficulties.

In addition to GYNETRONICS LTD, another remarkable startup, IQ3SOLAR LTD, has emerged as a result of the relentless efforts of a research team at the esteemed FOSS (Energy Research Center) at the University of Cyprus. IQ3SOLAR LTD has successfully created a non-intrusive sensor that swiftly detects potential damages in Photovoltaic Systems. This cutting-edge solution not only helps safeguard investments in solar energy but also significantly contributes to energy conservation, resulting in substantial cost savings and positive environmental implications.

Eurobank Cyprus emphasizes its commitment to supporting initiatives that bolster the Cypriot economy and foster sustainable development. Cyprus Seeds, in particular, has received significant backing from the bank. In addition to nurturing these groundbreaking startups, Cyprus Seeds has also extended support to the “Gene therapy” project led by the Institute of Neurology and Genetics. This pioneering endeavor has recently inked a Licensing Agreement with leading American pharmaceutical companies to develop genetic therapies for various demyelinating neurodegenerative disorders.

Looking ahead, Eurobank Cyprus remains steadfast in its determination to continue supporting initiatives like Cyprus Seeds, which not only drive the creation of new job opportunities for highly skilled individuals and scientists within Cyprus but also fuel a vibrant culture of innovative entrepreneurship. By doing so, these initiatives not only attract investments but also provide intelligent and practical solutions to societal, economic, and market needs.

Eurobank Cyprus's unwavering commitment to research and innovation is evident in its endeavors to foster a thriving ecosystem that nurtures groundbreaking ideas and transforms them into impactful ventures. As the bank looks to the future, it is dedicated to further propelling the Cypriot economy, driving sustainable growth, and fostering a shift towards innovative entrepreneurship.

Eurobank Cyprus Ltd, a subsidiary of Eurobank SA, distinguishes itself in the Cypriot banking sector with its unique business model. With eight banking centers across major cities in Cyprus, the company specializes in wholesale banking services, corporate banking, wealth management, international business banking, and global markets. Established in 2007, Eurobank Cyprus Ltd boasts robust capital adequacy ratios, financial strength, and substantial liquidity after many years of successful operation and continuous growth.